Total submissions: 14
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000118289 | SCV000231115 | benign | not specified | 2014-10-22 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000118289 | SCV000312089 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Athena Diagnostics Inc | RCV000713160 | SCV000843739 | benign | not provided | 2018-05-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002312502 | SCV000846150 | benign | Inborn genetic diseases | 2015-12-31 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV001520527 | SCV001729646 | benign | Early infantile epileptic encephalopathy with suppression bursts | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000713160 | SCV001848261 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001807075 | SCV002054559 | benign | Myoclonus, familial, 2 | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001807072 | SCV002054560 | benign | Cognitive impairment with or without cerebellar ataxia | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001807073 | SCV002054561 | benign | Developmental and epileptic encephalopathy, 13 | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001807074 | SCV002054563 | benign | Seizures, benign familial infantile, 5 | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000118289 | SCV000152661 | likely benign | not specified | no assertion criteria provided | clinical testing | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. | |
Diagnostic Laboratory, |
RCV000118289 | SCV001742549 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000118289 | SCV001956774 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000118289 | SCV001973505 | benign | not specified | no assertion criteria provided | clinical testing |